Search Login Register

Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) Summary

Description: Conditions with abnormally low levels of ALPHA-LIPOPROTEINS (high-density lipoproteins) in the blood. Hypoalphalipoproteinemia can be associated with mutations in genes encoding APOLIPOPROTEIN A-I; LECITHIN CHOLESTEROL ACYLTRANSFERASE; and ATP-BINDING CASSETTE TRANSPORTERS.

Also Known As: Hypoalphalipoproteinemia; Familial High-Density Lipoprotein Deficiency Disease; Familial alpha-Lipoprotein Deficiency Disease; HDL Lipoprotein Deficiency Disease; High-Density Lipoprotein Deficiency Disease, Familial Show All >>

Networked: 154 relevant articles (4 outcomes, 19 trials/studies) for this Disease

Key Drugs and Agents for Hypoalphalipoproteinemias

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:

HDL Cholesterol : 2 outcomes 3 studies in 41 results : IBA
Lipoproteins (Lipoprotein) : 1 outcome 7 studies in 34 results : IBA
Gemfibrozil (Lopid) : 1 outcome 2 studies in 4 results : FDA 17 Generic
Triglycerides (Triacylglycerol) : 1 outcome 1 study in 10 results : IBA
LDL Cholesterol : 1 outcome 1 study in 7 results : IBA
Lovastatin (Mevacor) : 1 outcome 1 study in 3 results : FDA 14 Generic
avasimibe : 1 outcome 1 study in 2 results : IBA
Chylomicrons : 1 outcome in 1 result : IBA
Bezafibrate : 1 outcome in 1 result : IBA
Cholesterol : 4 studies in 27 results : IBA

Show All >>

Diseases Related to Hypoalphalipoproteinemias

Show All >>

Key Therapies for Hypoalphalipoproteinemias

Efficacy Chart >>